S. Jeffs

发表

A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment

Q. Sattentau, G. Krashias, F. Wegmann, 2011, PloS one.

Airway structural cells regulate TLR5-mediated mucosal adjuvant activity

J. Sirard, B. Ryffel, A. Benecke, 2013, Mucosal Immunology.

DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4

Yufei Wang, G. Vanham, C. Kelly, 2011, PloS one.

Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120.

S. Zolla-Pazner, M. Gorny, S. Jeffs, 2001, Immunology letters.

Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein.

H. Craft, J. McKeating, S. Jeffs, 1996, The Journal of general virology.

Comparative analysis of HIV-1 recombinant envelope glycoproteins from different culture systems

G. Stacey, S. Jeffs, C. Yuen, 2006, Applied Microbiology and Biotechnology.

Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses

S. Jeffs, R. Shattock, M. Seaman, 2010, Mucosal Immunology.

The production, characterisation and application of monoclonal antibodies generated by immunisation with HIV-1C clade RGP140 envelope protein.

S. Jeffs, I. Jones, Hongying Chen, 2013, Journal of virological methods.

Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display.

Angray S. Kang, S. Jeffs, Á. McKnight, 2012, Human antibodies.

Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering

Renate Kunert, Alexander Goesmann, Stephan H. Bernhart, 2011, Journal of biotechnology.

Structure of Sm25, an antigenic integral membrane glycoprotein of adult Schistosoma mansoni.

A. Simpson, F. Hackett, S. Jeffs, 1991, Molecular and biochemical parasitology.

Echinococcus granulosus (Cestoda): uptake of L-amino acids by secondary hydatid cysts

S. Jeffs, C. Arme, 1988, Parasitology.

Echinococcus granulosus: specificity of amino acid transport systems in protoscoleces

S. Jeffs, C. Arme, 1987, Parasitology.

Echinococcus granulosus: absorption of cycloleucine and α-aminoisobutyric acid by protoscoleces

S. Jeffs, C. Arme, 1986, Parasitology.

Hymenolepis diminuta: Characterization of the neutral amino acid transport loci of the metacestode

S. Jeffs, C. Arme, 1985 .

Hymenolepis diminuta (Cestoda): uptake of cycloleucine by metacestodes.

S. Jeffs, C. Arme, 1985, Comparative biochemistry and physiology. A, Comparative physiology.

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.

Q. Sattentau, M. Neuberger, M. Brüggemann, 2011, Protein engineering, design & selection : PEDS.

Partial characterization and kinetics of expression of Sm15, aSchistosoma mansoni tegumental antigen

A. Simpson, S. Jeffs, F. Abath, 2004, Parasitology Research.

Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

Q. Sattentau, D. Montefiori, W. Weissenhorn, 2010, PloS one.

Hymenolepis diminuta: protein synthesis in cysticercoids

S. Jeffs, C. Arme, 1984, Parasitology.

Kinetics of molecular transfer across the tegument of protoscoleces and hydatid cysts of Echinococcus granulosus and the relevance of these studies to drug targeting

S. Jeffs, H. Hurd, C. Arme, 1987 .

Molecular cloning and characterisation of the 22-kilodalton adult Schistosoma mansoni antigen recognised by antibodies from mice protectively vaccinated with isolated tegumental surface membranes.

A. Simpson, R. Corrêa-Oliveira, S. Jeffs, 1991, Molecular and biochemical parasitology.

Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity.

Q. Sattentau, P. Kwong, L. Kong, 2010, Journal of molecular biology.

Production and Characterization of High-Affinity Human Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in a Mouse Model Expressing Human Immunoglobulins

Q. Sattentau, N. Sheppard, S. Vieira, 2006, Clinical and Vaccine Immunology.

Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally

S. Jeffs, R. Shattock, T. Cole, 2011, PloS one.

Structure of the gene encoding a putative Schistosoma mansoni tegumental antigen precursor.

A. Holder, A. Simpson, S. Jeffs, 1993, Molecular and biochemical parasitology.

Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein

Joshua L. Phillips, Sandrasegaram Gnanakaran, Gianguido C. Cianci, 2013, Retrovirology.

Preclinical evaluation of the immunogenicity of C-type HIV-1-based DNA and NYVAC vaccines in the Balb/C mouse model.

R. Wagner, J. Köstler, S. Vieira, 2009, Viral immunology.

Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein.

J. McKeating, S. Jeffs, P. Balfe, 1996, Immunology letters.

Truncated gp120 envelope glycoprotein of human immunodeficiency virus 1 elicits a broadly reactive neutralizing immune response.

J. McKeating, S. Jeffs, P. Balfe, 2002, The Journal of general virology.

Expression and characterisation of recombinant oligomeric envelope glycoproteins derived from primary isolates of HIV-1.

Q. Sattentau, S. Jeffs, H. Holmes, 2004, Vaccine.

Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci.

Q. Sattentau, M. Neuberger, M. Brüggemann, 2011, Protein engineering, design & selection : PEDS.